Search Login Register

Epidermolytic Palmoplantar Keratoderma Summary

47 relevant articles (0 outcomes, 1 trials/studies) found for this Disease

Description: An autosomal dominant hereditary skin disease characterized by epidermolytic hyperkeratosis that is strictly confined to the palms and soles. It has been associated with mutations in the gene that codes for KERATIN-9.

Also Known As: Keratoderma, Palmoplantar, Epidermolytic; EPPK (Epidermolytic Palmoplantar Keratoderma); Thost-Unna Disease, Epidermolytic; Unna-Thost Disease, Epidermolytic; EPPKs (Epidermolytic Palmoplantar Keratoderma) Show All >>

Key Drugs and Agents for Epidermolytic Palmoplantar Keratoderma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Type I Keratins (Type I Keratin) : 1 study in 3 results : IBA
  2. Keratin-9 (Keratin 9) : 30 results : IBA
  3. Keratins (Keratin) : 11 results : IBA
  4. Keratin-1 : 3 results : IBA
  5. Type II Keratins (Type II Keratin) : 2 results : IBA
  6. Keratin-16 (Keratin 16) : 1 result : IBA
  7. Leucine (L-Leucine) : 1 result : FDA 31
  8. Etretinate : 1 result : FDA 1
  9. calcipotriene (calcipotriol) : 1 result : FDA 4
  10. K-18 conjugate (K18) : 1 result : IBA
Show All >>

Diseases Related to Epidermolytic Palmoplantar Keratoderma

  1. Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
  2. Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma)
  3. Ichthyosis Bullosa of Siemens
  4. Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome)
  5. Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
Show All >>

Key Therapies for Epidermolytic Palmoplantar Keratoderma

Efficacy Chart >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.